DRAXXIN 25 DIN 02430711
Status: Marketed
Holder: ZOETIS CANADA INC
Health Canada record
| Active ingredient(s) | TULATHROMYCIN 25 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Intramuscular |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 02-Dec-2015 |
|---|
| Current status date | 02-Jun-2020 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TULATHROMYCIN
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02532859 | AROVYN | INTERVET CANADA CORP | Solution | TULATHROMYCIN 100 MG | Approved |
| 02285452 | DRAXXIN | ZOETIS CANADA INC | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02516683 | DRAXXIN KP | ZOETIS CANADA INC | Solution | TULATHROMYCIN 100 MG; KETOPROFEN 120 MG | Marketed |
| 02516500 | INCREXXA | ELANCO CANADA LIMITED | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02508990 | LYDAXX | VETOQUINOL N A INC | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02544229 | MACROSYN | BIMEDA-MTC ANIMAL HEALTH INC | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02536013 | TULAJECT | ALIVIRA ANIMAL HEALTH LIMITED | Solution | TULATHROMYCIN 100 MG | Approved |
| 02502151 | TULAVEN | CEVA ANIMAL HEALTH INC | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02530155 | TULINOVET | MODERN VETERINARY THERAPEUTICS LLC | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02502879 | TULISSIN | VIRBAC AH, INC. | Solution | TULATHROMYCIN 100 MG | Marketed |
| 02536277 | TULISSIN 25 | VIRBAC AH, INC. | Solution | TULATHROMYCIN 25 MG | Approved |
| 02560348 | VACASAN | PARNELL TECHNOLOGIES PTY LTD | Solution | TULATHROMYCIN 100 MG | Approved |
| 02518236 | REXXOLIDE | DECHRA REGULATORY BV | Solution | TULATHROMYCIN 100 MG | Dormant |
| 02505401 | TULIEVE | NORBROOK LABORATORIES LTD. | Solution | TULATHROMYCIN 100 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 28727 | 2022-08-11 | Supplement to a New Drug Submission (SNDS) | ADDITION OF A NEW DRUG PRODUCT MANUFACTURING, PACKAGING AND TESTING SITE AND LABELLING UPDATE |
| 16030 | 2014-09-04 | Supplement to a New Drug Submission (SNDS) | NEW STRENGTH |
Request a quote for DRAXXIN 25
How to read a Canadian DIN record